Tagrisso is used to treat patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC).
The recommended dosage is one tablet taken orally once daily, with or without food, until disease progression or unacceptable toxicity.
Do not use Tagrisso for a condition for which it was not prescribed. Do not give Tagrisso to other people, even if they have the same symptoms you have. If you would like more information about Tagrisso, talk with your provider or ask our pharmacists.
Read More >>
This exclusive downloadable decision-making guide helps you select a specialty pharmacy for your oncology practice by answering important questions such as:
The Latest Oncology Medication Information & Patient Resources from Avella Specialty Pharmacy.
Subscribe to email updates including Oncology news, innovations and breakthroughs, policy updates & public health info.
Access the latest and most up-to-date Oncology treatment resource information for your patients and their families.
